Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatic ischemia-reperfusion injury (IRI) could result in severe liver damage and dysfunction during liver surgery and transplantation. As one of the Interferon (IFN)-stimulated genes,
IFIT3
exerted antitumor activity but its roles in hepatic IRI are still unknown. In this study, roles of
IFIT3
in hepatic IRI were investigated using a mouse hepatic IRI model and a cellular hypoxia-reoxygenation model. Firstly, our results showed that
IFIT3
was up-regulated in reperfused liver tissues of patients undergoing liver transplantation and was positively correlated with serum alanine aminotransferase (ALT) and
aspartate aminotransferase
(
AST
). Secondly, knockdown of
IFIT3
could significantly ameliorate hepatic IRI and suppress ischemia and reperfusion-induced release of inflammatory cytokines in vivo and in vitro. Furthermore, knockdown of
IFIT3
inhibited phosphorylation of STAT1 and STAT2, and decreased expressions of IFN-stimulated genes induced by ischemia and reperfusion in vivo and in vitro. These data highlight the importance and potential clinical use of
IFIT3
in hepatic IRI.
...
PMID:Down-regulation of IFIT3 protects liver from ischemia-reperfusion injury. 2973 33